Datapathology

Datapathology, established in Casablanca, Morocco, in 2020, is a medical technology company focused on addressing delays in cancer diagnosis within Africa. The company was co-founded by Dr. Hicham El Attar, a pathologist, and Mohammed El Khannoussi, a data and IT consultant. Their combined expertise in medicine and technology forms the foundation of the company's approach to revolutionizing pathology diagnostics. Dr. El Attar brings extensive experience as a pathologist, while Mr. El Khannoussi provides the data and systems integration knowledge necessary to build a digital health platform.

The company operates in the growing digital pathology market in Africa, which is projected to expand significantly due to the rising demand for more accurate and faster diagnostics. Datapathology serves a clientele of hospitals, multidisciplinary clinics, and pathology centers that are contending with an increasing number of cancer cases and a shortage of pathologists. Its business model revolves around providing a comprehensive, fully digital, AI-based solution that digitizes the diagnostic workflow. The process involves preparing a tissue sample from a biopsy at the patient's location, scanning it into a high-resolution digital file, and securely transferring it via a web platform to a team of pathologists for remote diagnosis. This system aims to deliver diagnoses quickly and efficiently.

Datapathology's core service is its digital telepathology platform, which facilitates remote diagnosis and offers AI-powered decision support tools. The company provides both the hardware and software required for clients to adopt digital pathology. A key achievement for the startup was the establishment of the first digital pathological diagnosis center in Morocco. Since its inception, the company has successfully processed over 1,200 diagnostic cases and launched the first digital cervical screening platform in Morocco, as well as a digital lab service in Djibouti. Datapathology has secured multiple rounds of funding, including an initial $223,000 in 2021 and a subsequent $1 million in 2023, to expand its network of laboratories across Morocco and Africa and to further develop its AI-based screening solutions for various cancers.

Keywords: digital pathology, telepathology, cancer diagnosis, medical technology, pathology diagnostics, AI in healthcare, remote diagnosis, Morocco healthcare, African healthtech, biopsy analysis, pathology workflow, cervical screening, diagnostic solutions, pathology laboratory services, medical imaging, healthcare data, e-health, oncology diagnostics, pathology AI, histology digitization